# Beyond Air to Participate in the 2026 Cantor Global Healthcare Conference
Canonical URL: https://biopharmsignal.com/news/XAIR/beyond-air-to-participate-in-the-2026-cantor-global-healthcare-conference-6e406389
Ticker: XAIR
Company: Beyond Air
Source: Beyond Air
Published: 2026-09-02 12:00 EST
## Summary

Beyond Air, Inc. (NASDAQ: XAIR), a commercial-stage medical device and biopharmaceutical company...

## Article Body
Beyond Air, Inc. (NASDAQ: XAIR), a commercial-stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve patients' lives, today announced that its management team will participate in the 2026 Cantor Global Healthcare Conference, which is being held at the Waldorf Astoria New York, New York on September 9-11, 2026.

Fireside Chat Details: Date: Thursday, September 10 th Time: 3:55 PM EDT Webcast Link: A live webcast of the fireside chat will be available on the Events section of the Company’s website, https://www.beyondair.net/news-events/events . Following the live presentation, a replay of the webcast will be available on the Company's website for 90 days.

If you are interested in requesting a one-on-one meeting at the conference, please contact your Cantor representative to schedule accordingly.

About Beyond Air, Inc. Beyond Air is a commercial-stage medical device and biopharmaceutical company dedicated to harnessing the power of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders, and solid tumors. The Company has received FDA approval and CE Mark for its first system, LungFit PH, for the treatment of term and near-term neonates with hypoxic respiratory failure. For more information, visit www.beyondair.net.

CONTACTS:

Corey Davis, Ph.D. LifeSci Advisors, LLC Cdavis@lifesciadvisors.com (212) 915-2577
## Recent Company News
- 2026-09-02 12:00 EST — [Beyond Air to Participate in the 2026 Cantor Global Healthcare Conference](https://biopharmsignal.com/news/XAIR/beyond-air-to-participate-in-the-2026-cantor-global-healthcare-conference-6e406389) — Source: Beyond Air
- 2026-08-31 12:00 EST — [Beyond Air® Receives FDA Breakthrough Device Designation for LungFit® GO to Treat Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD)](https://biopharmsignal.com/news/XAIR/beyond-air-receives-fda-breakthrough-device-designation-for-lungfit-go-to-treat--aedb37d4) — Source: Beyond Air
- 2026-08-25 11:00 EST — [Beyond Air Enters Definitive Agreement to Sell Its NeuroNOS Stake to UNIVO Pharmaceutical Industries in Exchange for Equity and Milestone Payments](https://biopharmsignal.com/news/XAIR/beyond-air-enters-definitive-agreement-to-sell-its-neuronos-stake-to-univo-pharm-44cfb6b7) — Source: Beyond Air
- 2026-08-13 11:00 EST — [Beyond Air® Reports Financial Results for the Quarter Ended June 30, 2026 and Provides Corporate Update](https://biopharmsignal.com/news/XAIR/beyond-air-reports-financial-results-for-the-quarter-ended-june-30-2026-and-prov-419dcf14) — Source: Beyond Air
- 2026-08-04 12:00 EST — [Beyond Air Schedules Conference Call to Discuss Financial Results for the Quarter Ended June 30, 2026](https://biopharmsignal.com/news/XAIR/beyond-air-schedules-conference-call-to-discuss-financial-results-for-the-quarte-a4714eb0) — Source: Beyond Air
## Related News
- 2026-09-04 20:30 EST — ORIC — [ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/ORIC/oric-pharmaceuticals-reports-inducement-grants-under-nasdaq-listing-rule-5635-c--e23953dd)
- 2026-09-04 20:05 EST — RPID — [Rapid Micro Biosystems to Participate in Upcoming Investor Conferences](https://biopharmsignal.com/news/RPID/rapid-micro-biosystems-to-participate-in-upcoming-investor-conferences-91a8800f)
- 2026-09-04 20:05 EST — LIXT — [NOMAD POWER SOLUTIONS ANNOUNCES ADJOURNMENT OF SPECIAL MEETING OF STOCKHOLDERS](https://biopharmsignal.com/news/LIXT/nomad-power-solutions-announces-adjournment-of-special-meeting-of-stockholders-74cd9e2e)
- 2026-09-04 20:05 EST — AVTX — [Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/AVTX/avalo-therapeutics-announces-inducement-grants-to-new-employees-under-nasdaq-lis-cc7baaf2)
- 2026-09-04 20:05 EST — NTLA — [Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/NTLA/intellia-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-250d5dd9)